Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial.
Bissonnette R, Pavel AB, Diaz A, Werth JL, Zang C, Vranic I, Purohit VS, Zielinski MA, Vlahos B, Estrada YD, Saint-Cyr Proulx E, Ports WC, Guttman-Yassky E. Bissonnette R, et al. Among authors: vlahos b. J Allergy Clin Immunol. 2019 Nov;144(5):1274-1289. doi: 10.1016/j.jaci.2019.06.047. Epub 2019 Aug 13. J Allergy Clin Immunol. 2019. PMID: 31419544 Free article. Clinical Trial.
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
Schlessinger J, Shepard JS, Gower R, Su JC, Lynde C, Cha A, Ports WC, Purohit V, Takiya L, Werth JL, Zang C, Vlahos B; CARE 1 Investigators. Schlessinger J, et al. Among authors: vlahos b. Am J Clin Dermatol. 2020 Apr;21(2):275-284. doi: 10.1007/s40257-020-00510-6. Am J Clin Dermatol. 2020. PMID: 32212104 Free PMC article. Clinical Trial.
Vehicles for atopic dermatitis therapies: more than just a placebo.
Danby SG, Draelos ZD, Gold LFS, Cha A, Vlahos B, Aikman L, Sanders P, Wu-Linhares D, Cork MJ. Danby SG, et al. Among authors: vlahos b. J Dermatolog Treat. 2022 Mar;33(2):685-698. doi: 10.1080/09546634.2020.1789050. Epub 2020 Jul 16. J Dermatolog Treat. 2022. PMID: 32654550 Free article. Review.
Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild-to-moderate atopic dermatitis.
Eichenfield LF, Yosipovitch G, Stein Gold LF, Kalabis M, Zang C, Vlahos B, Sanders P, Myers DE, Bushmakin AG, Cappelleri JC, Olivadoti M, Paller AS. Eichenfield LF, et al. Among authors: vlahos b. Pediatr Dermatol. 2020 Nov;37(6):1030-1037. doi: 10.1111/pde.14328. Epub 2020 Sep 27. Pediatr Dermatol. 2020. PMID: 32981097 Free PMC article. Clinical Trial.
Skin permeation and penetration of crisaborole when coapplied with emollients.
Draelos ZD, Ports WC, Vlahos B, Yeoh T, Wu-Linhares D, Brown MB, Lenn J, Thombre AG. Draelos ZD, et al. Among authors: vlahos b. J Am Acad Dermatol. 2020 Dec;83(6):1801-1803. doi: 10.1016/j.jaad.2020.03.114. Epub 2020 Oct 14. J Am Acad Dermatol. 2020. PMID: 33069458 Free article. No abstract available.
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study.
Eichenfield LF, Gower RG, Xu J, Alam MS, Su JC, Myers DE, Sanders P, Vlahos B, Zang C, Lan J, Werth J. Eichenfield LF, et al. Among authors: vlahos b. Am J Clin Dermatol. 2023 Jul;24(4):623-635. doi: 10.1007/s40257-023-00780-w. Epub 2023 May 15. Am J Clin Dermatol. 2023. PMID: 37184828 Free PMC article. Clinical Trial.
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study.
Silverberg JI, Kirsner RS, Margolis DJ, Tharp M, Myers DE, Annis K, Graham D, Zang C, Vlahos BL, Sanders P. Silverberg JI, et al. Among authors: vlahos bl. J Am Acad Dermatol. 2024 May;90(5):945-952. doi: 10.1016/j.jaad.2023.12.048. Epub 2024 Feb 8. J Am Acad Dermatol. 2024. PMID: 38340127 Free article. Clinical Trial.
A phase 3 randomized, double-blind, multicenter comparative study evaluating the effect of etanercept versus methotrexate on radiographic outcomes, disease activity, and safety in Japanese subjects with active rheumatoid arthritis.
Takeuchi T, Miyasaka N, Zang C, Alvarez D, Fletcher T, Wajdula J, Yuasa H, Vlahos B. Takeuchi T, et al. Among authors: vlahos b. Mod Rheumatol. 2013 Jul;23(4):623-33. doi: 10.1007/s10165-012-0742-6. Epub 2012 Sep 26. Mod Rheumatol. 2013. PMID: 23011358 Clinical Trial.
51 results